Novel Drug Targets for Central Apneas in Heart Failure: On the Road
- PMID: 34086532
- PMCID: PMC8480255
- DOI: 10.1164/rccm.202104-0846LE
Novel Drug Targets for Central Apneas in Heart Failure: On the Road
Comment in
-
Reply to Borrelli et al.: Novel Drug Targets for Central Apneas in Heart Failure: On the Road.Am J Respir Crit Care Med. 2021 Aug 15;204(4):491. doi: 10.1164/rccm.202104-1076LE. Am J Respir Crit Care Med. 2021. PMID: 34086535 Free PMC article. No abstract available.
Comment on
-
Research Priorities for Patients with Heart Failure and Central Sleep Apnea. An Official American Thoracic Society Research Statement.Am J Respir Crit Care Med. 2021 Mar 15;203(6):e11-e24. doi: 10.1164/rccm.202101-0190ST. Am J Respir Crit Care Med. 2021. PMID: 33719931 Free PMC article.
References
-
- Emdin M, Mirizzi G, Giannoni A, Poletti R, Iudice G, Bramanti F, et al. Prognostic significance of central apneas throughout a 24-hour period in patients with heart failure. J Am Coll Cardiol . 2017;70:1351–1364. - PubMed
-
- Giannoni A, Gentile F, Sciarrone P, Borrelli C, Pasero G, Mirizzi G, et al. Upright Cheyne-Stokes respiration in patients with heart failure. J Am Coll Cardiol . 2020;75:2934–2946. - PubMed
-
- Giannoni A, Emdin M, Bramanti F, Iudice G, Francis DP, Barsotti A, et al. Combined increased chemosensitivity to hypoxia and hypercapnia as a prognosticator in heart failure. J Am Coll Cardiol . 2009;53:1975–1980. - PubMed
-
- Teran FA, Richerson GB. In: Handbook of the behavioral neurobiology of serotonin, second edition. Müller CP, Cunningham KA, editors. London: 2020. 5-HT neurons and central CO2 chemoreception; pp. 377–391.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical